Prospective study of infective endocarditis among injection drug users
No Thumbnail Available
Links to Files
Permanent Link
Author/Creator ORCID
Date
2002-06-15
Type of Work
Department
Program
Citation of Original Publication
Lucy E. Wilson and others, Prospective study of infective endocarditis among injection drug users, The Journal of Infectious Diseases, Volume 185, Issue 12, 15 June 2002, Pages 1761–1766, https://doi.org/10.1086/340827
Rights
This item is likely protected under Title 17 of the U.S. Copyright Law. Unless on a Creative Commons license, for uses protected by Copyright Law, contact the copyright holder or the author.
Abstract
To determine the effect of human immunodeficiency virus (HIV) infection and other factors on infective endocarditis (IE) among injection drug users (IDUs), the incidence of IE was determined according to HIV status in a cohort of IDUs. A nested case-control study assessed IE risk factors. IE incidence (117 cases) was higher among HIV-seropositive than HIV-seronegative IDUs (13.8 vs. 3.3 cases/1000 person-years) during 1988–1998. Multivariate analysis of HIV-infected case patients revealed an inverse association between IE and CD4 lymphocyte count (odds ratio [OR] for 200–499 cells/mm³, 2.01; OR for < 200 cells/mm³, 3.61) and with alcohol intake (OR for 1–21 drinks/week, 0.43; OR for > 21 drinks/week, 0.32). Women had an increased risk of IE (OR, 3.26), as did persons with increasing injection drug use frequency (OR for less than daily use, 3.15; OR for at least daily use, 6.07). This study confirms that IE is more common among IDUs with advanced HIV immunosuppression even after accounting for injection drug use behaviors.